News

CvilleBioHub Appoints Nikki Hastings as President, Marking New Phase of Growth and Regional Leadership

CvilleBioHub today announced that its Board of Directors has appointed Nikki Hastings as President, recognizing her leadership in building the organization into a cornerstone of Central Virginia’s life sciences ecosystem and positioning it for continued growth and influence.

The appointment comes as CvilleBioHub prepares to celebrate its 10th anniversary and marks one year since the launch of the Commonwealth BioAccelerator—milestones that underscore the organization’s accelerating impact across the region.

Since co-founding CvilleBioHub, Hastings has led the organization’s evolution from an emerging, community-focused initiative into a sought-after resource for founders, researchers, and industry partners. Under her leadership, CvilleBioHub has expanded its programming, strengthened institutional partnerships, and advanced its mission to support high-potential life sciences companies on a path to commercialization.

“This organization is growing in scope and influence and Nikki is shaping its future, not just running the day-to-day operations,” said Payam Pourtaheri, Board Chair of CvilleBioHub. “Her appointment as President reflects both the scale of what CvilleBioHub has become and the ambition of where the organization is headed. Nikki has built deep credibility with funders, institutional partners, and entrepreneurs alike, and she continues to elevate this region as a hub for life sciences innovation.”

The transition in title reflects a broader shift for CvilleBioHub as it enters a new phase defined by increased visibility, expanded partnerships, and a growing role as an ecosystem leader across Virginia and beyond.

“What started as a shared vision has grown into something far more impactful than we imagined,” said Martin Chapman, Co-Founder and Board Emeritus. “Nikki has been at the center of that growth from day one. Her leadership, persistence, and belief in what this region can become have helped turn CvilleBioHub into a true catalyst for innovation.”

As President, Hastings will continue to guide CvilleBioHub’s strategic direction, deepen its partnerships with public and private stakeholders, and expand the reach of the Commonwealth BioAccelerator to support the next generation of life sciences companies.

“I’m incredibly proud of what we’ve built together over the past decade,” said Hastings. “As we look ahead, the opportunity is even greater to strengthen this ecosystem, support exceptional founders, and ensure Virginia continues to emerge as a leader in life sciences innovation.”

Recent News

08/14/2026

Transforming the finance function in life sciences: Empower scalable growth

Life sciences companies operate in one of the most complex business environments. Long R&D timelines, limited early-stage revenue, and dependence on external funding create a financial landscape where every decision carries strategic weight. In this context, finance is not a back-office function. It is an operational engine that drives whether a company survives, scales, or

08/11/2026

Pascal Medical Corporation Secures $3.8M to Advance ClickGel Into Pivotal Large Animal Testing

Pascal Medical Corporation has raised $3.8 million to push its ClickGel surgical sealant through pivotal large animal testing on the way to human trials. The total combines a $3 million private financing round closed in July with an $800,000 grant from Virginia Catalyst, announced by Governor Abigail Spanberger on July 30, 2026. Pascal will use

08/10/2026

Expanding visibility with wearable blood pressure monitoring: CareTaker

In higher-risk patient populations, across all points of care, a patient’s condition can deteriorate quickly between routine vital sign checks, creating critical gaps in visibility and leaving clinical deterioration undetected between rounds. Continuous clinical-grade non-invasive blood pressure (CNIBP) monitoring, combined with hemodynamic trending, helps close these gaps by providing a more complete view of patient